# Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)

> **NCT01207648** · — · COMPLETED · sponsor: **EMD Serono** · enrollment: 307 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Rebif®

## Key facts

- **NCT ID:** NCT01207648
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 307 (ACTUAL)
- **Last updated:** 2015-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01207648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01207648, "Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01207648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*